https://m2.mtmt.hu/ hun 2026-09-20 17:23 JournalArticle 32017001 VALIDATED true Funding Agency and Grant Number: National Research, Development and Innovation Office [K116295, TUDFO/51757/2019-ITM, TKP2020-NKA-26] Funding text: This research was funded by the National Research, Development and Innovation Office (K116295 JT), Hungary. Financial support of the molecular biology lab from the 2019 Thematic Excellence Program (TUDFO/51757/2019-ITM and TKP2020-NKA-26) is greatly acknowledged. 0 false 2026-08-11T09:07:44.408+0000 2022-03-29T07:24:14.577+0000 2021-05-16T09:09:55.980+0000 true 10043337 Szokol Bálint /api/author/10043337 Author Szokol Bálint (Gyógyszerkémia) true 10043337 2025-06-13T16:51:03.890+0000 2025-06-13T16:51:03.890+0000 2022-01-12T12:34:40.738+0000 true 10070075 Nádas Orsolya /api/admin/10070075 Admin Nádas Orsolya (OOI admin4) true 2022-02-09T12:06:46.098+0000 true 10062250 Molnár-Taga Márta /api/admin/10062250 Admin Molnár-Taga Márta (SE 4-es admin) true 10062250 Admin 10073918 /api/admin/10073918 Kovács Marcell (MTMT Közp., admin) Kovács Marcell true true 2022-09-12T07:03:41.885+0000 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Nelhűbel, Györgyi A. true true /api/journal/1035680 REVIEWED PATHOLOGY AND ONCOLOGY RESEARCH 1219-4956 1532-2807 true false 1035680 false 1035680 true 1219-4956 1532-2807 Journal FOREIGN_AND_HUNGARIAN 27 620256 620256 13 2021 Funding 1996992 /api/funding/1996992 (K116295) Támogató: NKFIH false true Funding 1996993 /api/funding/1996993 Tématerületi Kiválósági Program(TUDFO/51757/2019-ITM) Támogató: NKFIH false true Funding 1996994 /api/funding/1996994 (TKP2020-NKA-26) false true true 2021 true true true false true false GOLD 2026-08-11 true https://doi.org/10.3389/pore.2021.620256 9 0 9 9 0 9 9 8 8 8 8 8 8 9 0 0 9 9 9 9 0 1 1 Folyóiratcikk Journal Article 24 9 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2022 0 1 1 1 1 2023 0 0 0 0 0 2024 0 3 3 3 3 2025 0 4 4 4 4 2026 0 1 1 1 1 Q2 false 10003054 false false false 2021-06-02T10:07:19.631+0000 Fül-Orr-Gégészeti és Fej-Nyaksebészeti Klinika (SE / AOK / K); II. Sz. Gyermekgyógyászati Klinika (SE / AOK / K); II. Sz. Patológiai Intézet (SE / AOK / I); Országos Onkológiai Intézet 12 41 4 14 0 true 10073918 Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 96295840 /api/authorship/96295840 Nelhűbel, Györgyi A. [Nelhübel, Györgyi (Fül-orr-gégészet), szerző] II. Sz. Gyermekgyógyászati Klinika (SE / AOK / K) 1 0.071428575 true false false Author 10028038 /api/author/10028038 Nelhübel Györgyi (Fül-orr-gégészet) Nelhübel Györgyi true 10028038 true Nelhűbel Györgyi A. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96295841 /api/authorship/96295841 Cserepes, Mihály [Cserepes, Tamás Mihály (tumorbiológia, mo...), szerző] Országos Onkológiai Intézet 2 0.071428575 false false false Author 10050407 /api/author/10050407 Cserepes Tamás Mihály (tumorbiológia, molekuláris biológia) Cserepes Tamás Mihály true 10050407 true Cserepes Mihály true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96295842 /api/authorship/96295842 Szabó, Balázs [Szabó, Balázs (fül- orr- gégegyó...), szerző] Fül-Orr-Gégészeti és Fej-Nyaksebészeti Klinika (SE / AOK / K) 3 0.071 false false false Author 10023623 /api/author/10023623 Szabó Balázs (fül- orr- gégegyógyászat) Szabó Balázs true 10023623 true Szabó Balázs true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96295843 /api/authorship/96295843 Türk, Dóra [Türk, Dóra (Molekuláris biológia), szerző] 4 0.071 false false false Author 10030015 /api/author/10030015 Türk Dóra (Molekuláris biológia) Türk Dóra true 10030015 true Türk Dóra true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96295844 /api/authorship/96295844 Kárpáti, Adél 5 0.071428575 false false false Kárpáti Adél true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96295845 /api/authorship/96295845 Kenessey, István [Kenessey, István (Patológia, onkológia), szerző] Országos Onkológiai Intézet; II. Sz. Patológiai Intézet (SE / AOK / I) 6 0.071 false false false Author 10017547 /api/author/10017547 Kenessey István (Patológia, onkológia) Kenessey István true 10017547 true Kenessey István true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96295846 /api/authorship/96295846 Rásó, Erzsébet [Rásó, Erzsébet (Molekuláris biológia), szerző] II. Sz. Patológiai Intézet (SE / AOK / I) 7 0.071 false false false Author 10010460 /api/author/10010460 Rásó Erzsébet (Molekuláris biológia) Rásó Erzsébet true 10010460 true Rásó Erzsébet true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96295847 /api/authorship/96295847 Barbai, Tamás [Barbai, Tamás (patológia), szerző] II. Sz. Patológiai Intézet (SE / AOK / I) 8 0.071 false false false Author 10032261 /api/author/10032261 Barbai Tamás (patológia) Barbai Tamás true 10032261 true Barbai Tamás true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96295848 /api/authorship/96295848 Hegedűs, Zita [Hegedűs, Zita (pathologia), szerző] Országos Onkológiai Intézet 9 0.071 false false false Author 10025748 /api/author/10025748 Hegedűs Zita (pathologia) Hegedűs Zita true 10025748 true Hegedűs Zita true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96295849 /api/authorship/96295849 László, Viktória [László, Viktória (tumorbiologia), szerző] 10 0.071428575 false false false Author 10037177 /api/author/10037177 László Viktória (tumorbiologia) László Viktória true 10037177 true László Viktória true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96295850 /api/authorship/96295850 Szokol, Bálint [Szokol, Bálint (Gyógyszerkémia), szerző] 11 0.071428575 false false false Author 10043337 /api/author/10043337 Szokol Bálint (Gyógyszerkémia) Szokol Bálint true 10043337 true Szokol Bálint true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96295851 /api/authorship/96295851 Dobos, Judit 12 0.071428575 false false false Dobos Judit true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96295852 /api/authorship/96295852 Őrfi, László [Őrfi, László (Szerves- és Gyógy...), szerző] 13 0.071 false false false Author 10003054 /api/author/10003054 Őrfi László (Szerves- és Gyógyszerkémia) Őrfi László true 10003054 true Őrfi László true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96295853 /api/authorship/96295853 Tóvári, József ✉ [Tóvári, József (Daganatbiológia, ...), szerző] Országos Onkológiai Intézet 14 0.071 false true true Author 10009941 /api/author/10009941 Tóvári József (Daganatbiológia, áttétképzés) Tóvári József true 10009941 true Tóvári József true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 18786988 /api/publicationidentifier/18786988 DOI: 10.3389/pore.2021.620256 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true GOLD true IDENTICAL 10.3389/pore.2021.620256 https://doi.org/10.3389/pore.2021.620256 false true PublicationIdentifier 18881493 /api/publicationidentifier/18881493 WoS: 000650981300001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 000650981300001 https://www.webofscience.com/wos/woscc/full-record/000650981300001 false true PublicationIdentifier 18884917 /api/publicationidentifier/18884917 Scopus: 85105991866 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85105991866 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85105991866 true true PublicationIdentifier 20826478 /api/publicationidentifier/20826478 PubMed: 34257586 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 34257586 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34257586&dopt=Abstract true true SjrRating 11225850 /api/sjrrating/11225850 sjr:Q2 (2021) Scopus - Medicine (miscellaneous) PATHOLOGY AND ONCOLOGY RESEARCH 1219-4956 1532-2807 968 0.49 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2701 /api/classificationexternal/2701 Scopus - Medicine (miscellaneous) true 2701 true Q2 DIRECT true true Reference 20508223 /api/reference/20508223 1. Marur 2008: Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment, Mayo Clinic Proceedingsáprilis, 83, p. 489, DOI: 10.4065/83.4.489 1 10.4065/83.4.489 false true Reference 20508224 /api/reference/20508224 2. Döbrossy 2005: Epidemiology of Head and Neck Cancer: Magnitude of the Problem, Cancer Metastasis Rev, 24, p. 9, DOI: 10.1007/s10555-005-5044-4 2 10.1007/s10555-005-5044-4 false true Reference 20508225 /api/reference/20508225 3. Goerner 2010: Molecular Targeted Therapies in Head and Neck Cancer—an Update of Recent Developements -, Head Neck Oncol, 2, p. 8, DOI: 10.1186/1758-3284-2-8 3 10.1186/1758-3284-2-8 false true Reference 20508226 /api/reference/20508226 4. Mehra 2008: The Role of Cetuximab for the Treatment of Squamous Cell Carcinoma of the Head and Neck, Clin Adv Hematol Oncoloktóber, 6, p. 742 4 false true Reference 20508227 /api/reference/20508227 5. Zimmermann 2006: The Epidermal Growth Factor Receptor (EGFR) in Head and Neck Cancer: its Role and Treatment Implications, Radiat Oncol, 1, p. 11, DOI: 10.1186/1748-717x-1-11 5 10.1186/1748-717x-1-11 false true Reference 20508228 /api/reference/20508228 6. Chung 2006: Increased Epidermal Growth Factor Receptor Gene Copy Number Is Associated with Poor Prognosis in Head and Neck Squamous Cell Carcinomas, Jco, 24, p. 4170, DOI: 10.1200/jco.2006.07.2587 6 10.1200/jco.2006.07.2587 false true Reference 20508229 /api/reference/20508229 7. Rogers 2005: Biological Significance of C-erbB Family Oncogenes in Head and Neck Cancer, Cancer Metastasis Rev, 24, p. 47, DOI: 10.1007/s10555-005-5047-1 7 10.1007/s10555-005-5047-1 false true Reference 20508230 /api/reference/20508230 8. Ali 2008: Expression and Mutation Analysis of Epidermal Growth Factor Receptor in Head and Neck Squamous Cell Carcinoma, Cancer Sci, 99, p. 1589, DOI: 10.1111/j.1349-7006.2008.00861.x 8 10.1111/j.1349-7006.2008.00861.x false true Reference 20508231 /api/reference/20508231 9. Temam 2007: Epidermal Growth Factor Receptor Copy Number Alterations Correlate with Poor Clinical Outcome in Patients with Head and Neck Squamous Cancer, Jco, 25, p. 2164, DOI: 10.1200/jco.2006.06.6605 9 10.1200/jco.2006.06.6605 false true Reference 20508232 /api/reference/20508232 10. Bonner 2006: Radiotherapy Plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck, N Engl J Med, 354, p. 567, DOI: 10.1056/nejmoa053422 10 10.1056/nejmoa053422 false true Reference 20508233 /api/reference/20508233 11. Vermorken 2008: Platinum-based Chemotherapy Plus Cetuximab in Head and Neck Cancer, N Engl J Med, 359, p. 1116, DOI: 10.1056/NEJMoa0802656 11 10.1056/NEJMoa0802656 false true Reference 20508234 /api/reference/20508234 12. Astsaturov 2006: EGFR-targeting Monoclonal Antibodies in Head and Neck Cancer, Ccdt, 6, p. 691, DOI: 10.2174/156800906779010191 12 10.2174/156800906779010191 false true Reference 20508235 /api/reference/20508235 13. Soulieres 2004: Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients with Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck, Jco, 22, p. 77, DOI: 10.1200/jco.2004.06.075 13 10.1200/jco.2004.06.075 false true Reference 20508236 /api/reference/20508236 14. Cohen 2003: Phase II Trial of ZD1839 in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, Jco, 21, p. 1980, DOI: 10.1200/jco.2003.10.051 14 10.1200/jco.2003.10.051 false true Reference 20508237 /api/reference/20508237 15. Cohen 2005: Phase II Trial of Gefitinib 250 Mg Daily in Patients with Recurrent And/or Metastatic Squamous Cell Carcinoma of the Head and Neck, Clin Cancer Res, 11, p. 8418, DOI: 10.1158/1078-0432.ccr-05-1247 15 10.1158/1078-0432.ccr-05-1247 false true Reference 20508238 /api/reference/20508238 16. Wheeler 2009: Epidermal Growth Factor Receptor Cooperates with Src Family Kinases in Acquired Resistance to Cetuximab, Cancer Biol Ther, 8, p. 696, DOI: 10.4161/cbt.8.8.7903 16 10.4161/cbt.8.8.7903 false true Reference 20508239 /api/reference/20508239 17. Wheeler 2008: Mechanisms of Acquired Resistance to Cetuximab: Role of HER (ErbB) Family Members, Oncogene, 27, p. 3944, DOI: 10.1038/onc.2008.19 17 10.1038/onc.2008.19 false true Reference 20508240 /api/reference/20508240 18. Braig 2017: Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K521 Polymorphism, Cancer Res, 77, p. 1188, DOI: 10.1158/0008-5472.can-16-0754 18 10.1158/0008-5472.can-16-0754 false true Reference 20508241 /api/reference/20508241 19. Benavente 2009: Establishment and Characterization of a Model of Acquired Resistance to Epidermal Growth Factor Receptor Targeting Agents in Human Cancer Cells, Clin Cancer Res, 15, p. 1585, DOI: 10.1158/1078-0432.ccr-08-2068 19 10.1158/1078-0432.ccr-08-2068 false true Reference 20508242 /api/reference/20508242 20. Boerner 2009: Role of Src Family Kinases in Acquired Resistance to EGFR Therapies in Cancer, Cancer Biol Ther, 8, p. 704, DOI: 10.4161/cbt.8.8.8183 20 10.4161/cbt.8.8.8183 false true Reference 20508243 /api/reference/20508243 21. Koppikar 2008: Combined Inhibition of C-Src and Epidermal Growth Factor Receptor Abrogates Growth and Invasion of Head and Neck Squamous Cell Carcinoma, Clin Cancer Res, 14, p. 4284, DOI: 10.1158/1078-0432.ccr-07-5226 21 10.1158/1078-0432.ccr-07-5226 false true Reference 20508244 /api/reference/20508244 22. Cortesina 2000: Staging of Head and Neck Squamous Cell Carcinoma Using theMET Oncogene Product as Marker of Tumor Cells in Lymph Node Metastases, Int J Cancer, 89, p. 286, DOI: 10.1002/1097-0215(20000520)89:3&lt;286::aid-ijc12&gt;3.0.co;2-u 22 10.1002/1097-0215(20000520)89:3&lt;286::aid-ijc12&gt;3.0.co;2-u false true Reference 20508245 /api/reference/20508245 23. Seiwert 2009: The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma, Cancer Res, 69, p. 3021, DOI: 10.1158/0008-5472.can-08-2881 23 10.1158/0008-5472.can-08-2881 false true Reference 20508246 /api/reference/20508246 24. Sattler 2003: A Novel Small Molecule Met Inhibitor Induces Apoptosis in Cells Transformed by the Oncogenic TPR-MET Tyrosine Kinase, Cancer Res, 63, p. 5462 24 false true Reference 20508247 /api/reference/20508247 25. Madoz-Gúrpide 2015: Activation of MET Pathway Predicts Poor Outcome to Cetuximab in Patients with Recurrent or Metastatic Head and Neck Cancer, J Transl Med, 13, p. 282, DOI: 10.1186/s12967-015-0633-7 25 10.1186/s12967-015-0633-7 false true Reference 20508248 /api/reference/20508248 26. Cohen 2014: Current Challenges and Clinical Investigations of Epidermal Growth Factor Receptor (EGFR)- and ErbB Family-Targeted Agents in the Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC), Cancer Treat Rev, 40, p. 567, DOI: 10.1016/j.ctrv.2013.10.002 26 10.1016/j.ctrv.2013.10.002 false true Reference 20508249 /api/reference/20508249 27. Zhao 2017: Mechanisms of Resistance to Anti-EGFR Therapy in Colorectal Cancer, Oncotarget, 8, p. 3980, DOI: 10.18632/oncotarget.14012 27 10.18632/oncotarget.14012 false true Reference 20508250 /api/reference/20508250 28. Bou-Assaly 2010: Cetuximab (Erbitux), AJNR Am J Neuroradiol, 31, p. 626, DOI: 10.3174/ajnr.a2054 28 10.3174/ajnr.a2054 false true Reference 20508251 /api/reference/20508251 29. Holubec 2016: The Role of Cetuximab in the Induction of Anticancer Immune Response in Colorectal Cancer Treatment, Ar, 36, p. 4421, DOI: 10.21873/anticanres.10985 29 10.21873/anticanres.10985 false true Reference 20508252 /api/reference/20508252 30. Trotta 2016: Prospective Evaluation of Cetuximab-Mediated Antibody-dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy, Cancer Immunol Res, 4, p. 366, DOI: 10.1158/2326-6066.cir-15-0184 30 10.1158/2326-6066.cir-15-0184 false true Reference 20508253 /api/reference/20508253 31. Wang 2017: HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models, Clin Cancer Res, 23, p. 677, DOI: 10.1158/1078-0432.ccr-16-0558 31 10.1158/1078-0432.ccr-16-0558 false true Reference 20508254 /api/reference/20508254 32. De Pauw 2018: Simultaneous Targeting of EGFR , HER 2, and HER 4 by Afatinib Overcomes Intrinsic and Acquired Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines, Mol Oncol, 12, p. 830, DOI: 10.1002/1878-0261.12197 32 10.1002/1878-0261.12197 false true Reference 20508255 /api/reference/20508255 33. Ather 2013: Dacomitinib, an Irreversible Pan-ErbB Inhibitor Significantly Abrogates Growth in Head and Neck Cancer Models that Exhibit Low Response to Cetuximab, PLoS One, 8, DOI: 10.1371/journal.pone.0056112 33 10.1371/journal.pone.0056112 false true Reference 20508256 /api/reference/20508256 34. Adkins 2018: Pazopanib Plus Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: an Open-Label, Phase 1b and Expansion Study, Lancet Oncol, 19, p. 1082, DOI: 10.1016/s1470-2045(18)30350-4 34 10.1016/s1470-2045(18)30350-4 false true Reference 20508257 /api/reference/20508257 35. Ouyang 2018: Induction of Anaplastic Lymphoma Kinase (ALK) as a Novel Mechanism of EGFR Inhibitor Resistance in Head and Neck Squamous Cell Carcinoma Patient-Derived Models, Cancer Biol Ther, 19, p. 921, DOI: 10.1080/15384047.2018.1451285 35 10.1080/15384047.2018.1451285 false true /api/publication/32017001 Nelhűbel Györgyi A. et al. EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas. (2021) PATHOLOGY AND ONCOLOGY RESEARCH 1219-4956 1532-2807 27<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10028038"><a href="/gui2/?type=authors&mode=browse&sel=10028038" target="_blank">Nelhűbel Györgyi A. (<span class="authorship-author-name">Nelhübel Györgyi</span> <span class="authorAux-mtmt"> Fül-orr-gégészet</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/II. Sz. Gyermekgyógyászati Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10050407"><a href="/gui2/?type=authors&mode=browse&sel=10050407" target="_blank">Cserepes Mihály (<span class="authorship-author-name">Cserepes Tamás Mihály</span> <span class="authorAux-mtmt"> tumorbiológia, molekuláris biológia</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10023623"><a href="/gui2/?type=authors&mode=browse&sel=10023623" target="_blank">Szabó Balázs (<span class="authorship-author-name">Szabó Balázs</span> <span class="authorAux-mtmt"> fül- orr- gégegyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Fül-Orr-Gégészeti és Fej-Nyaksebészeti Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10030015"><a href="/gui2/?type=authors&mode=browse&sel=10030015" target="_blank">Türk Dóra (<span class="authorship-author-name">Türk Dóra</span> <span class="authorAux-mtmt"> Molekuláris biológia</span>) </a> </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Kárpáti Adél </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10017547"><a href="/gui2/?type=authors&mode=browse&sel=10017547" target="_blank">Kenessey István (<span class="authorship-author-name">Kenessey István</span> <span class="authorAux-mtmt"> Patológia, onkológia</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/II. Sz. Patológiai Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10010460"><a href="/gui2/?type=authors&mode=browse&sel=10010460" target="_blank">Rásó Erzsébet (<span class="authorship-author-name">Rásó Erzsébet</span> <span class="authorAux-mtmt"> Molekuláris biológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/II. Sz. Patológiai Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10032261"><a href="/gui2/?type=authors&mode=browse&sel=10032261" target="_blank">Barbai Tamás (<span class="authorship-author-name">Barbai Tamás</span> <span class="authorAux-mtmt"> patológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/II. Sz. Patológiai Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10025748"><a href="/gui2/?type=authors&mode=browse&sel=10025748" target="_blank">Hegedűs Zita (<span class="authorship-author-name">Hegedűs Zita</span> <span class="authorAux-mtmt"> pathologia</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10037177"><a href="/gui2/?type=authors&mode=browse&sel=10037177" target="_blank">László Viktória (<span class="authorship-author-name">László Viktória</span> <span class="authorAux-mtmt"> tumorbiologia</span>) </a> </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10043337"><a href="/gui2/?type=authors&mode=browse&sel=10043337" target="_blank">Szokol Bálint (<span class="authorship-author-name">Szokol Bálint</span> <span class="authorAux-mtmt"> Gyógyszerkémia</span>) </a> </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Dobos Judit </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10003054"><a href="/gui2/?type=authors&mode=browse&sel=10003054" target="_blank">Őrfi László (<span class="authorship-author-name">Őrfi László</span> <span class="authorAux-mtmt"> Szerves- és Gyógyszerkémia</span>) </a> </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10009941"><a href="/gui2/?type=authors&mode=browse&sel=10009941" target="_blank">Tóvári József ✉ (<span class="authorship-author-name">Tóvári József</span> <span class="authorAux-mtmt"> Daganatbiológia, áttétképzés</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;32017001" target="_blank">EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas</a></div> <div> <span class="journal-title">PATHOLOGY AND ONCOLOGY RESEARCH</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1219-4956">1219-4956</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1532-2807">1532-2807</a>)</span>: <span class="journal-volume">27</span> <span class="page"> Paper 620256. 13 p. </span> <span class="year">(2021)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:blue" title="10.3389/pore.2021.620256" target="_blank" href="https://doi.org/10.3389/pore.2021.620256"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000650981300001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000650981300001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85105991866" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85105991866"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="34257586" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34257586&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Medicine (miscellaneous)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Pathology and Forensic Medicine&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Cancer Research&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q3</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Oncology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q3</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 9</span> | Független: 9 | Függő: 0 | Nem jelölt: 0 | WoS jelölt: 8 | Scopus jelölt:&nbsp;8 | WoS/Scopus jelölt:&nbsp;8 | DOI jelölt:&nbsp;9 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;32017001&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 1 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 32017001</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> (K116295) Támogató: NKFIH, Tématerületi Kiválósági Program(TUDFO/51757/2019-ITM) Támogató: NKFIH, (TKP2020-NKA-26) </div> <div class="lastModified">Utolsó módosítás: 2022.03.29. 09:24 László Viktória (tumorbiologia) </div> <div class="lockedBy">Központi kezelésű 2022.09.12. 09:03 Kovács Marcell (MTMT Közp., admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Megjegyzés</u>: Funding Agency and Grant Number: National Research, Development and Innovation Office [K116295, TUDFO/51757/2019-ITM, TKP2020-NKA-26] Funding text: This research was funded by the National Research, Development and Innovation Office (K116295 JT), Hungary. Financial support of the molecular biology lab from the 2019 Thematic Excellence Program (TUDFO/51757/2019-ITM and TKP2020-NKA-26...</pre> </div></div>